-
FDA Approves First Muscle-Targeted Therapy for SMA: A Conversation with Dr. Se-Jin Lee
The FDA has approved Isembyld (apitegromab-mstn), the first therapy designed to target muscle health and regeneration in people living with spinal muscular atrophy (SMA). This milestone adds to the progress made by genetic therapies for SMA and provides families with a new option focused on improving muscle strength and daily function. Se-Jin Lee, M.D., Ph.D.…
-
Life is so busy that a week of medical appointments sounds relaxing
My life is always in motion, and we are in a busy season as my family prepares to move into a new house, one that is being modified for accessibility. I share my life with my husband, Jason, and our seven children: Lexi, 25; Max, 20; Chance, 19; Rowen, 17; Charlie, 15; Mary, 11; and…








